Delivery Order SPE2DB24D2205-SPE2DB24FDVLN

Award Date 6/12/24
Potential Completion Date 6/13/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $31,029.48 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of June 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $64,538.10, with an Ultimate Completion Date of June 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $30,442.50 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,346.65 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of December 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,265.50 firm fixed price delivery order is for the supply of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has an ultimate completion date of July 25, 2024. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $134,213.45, is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines. The delivery order was issued under an Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $71,225.52 firm fixed-price contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,556.04 firm fixed price contract is for the delivery of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a vehicle for providing a wide...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,592.80 Firm Fixed Price delivery order contract is for the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with a completion date of February 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This $229,017.14 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,564,708,672 units of the MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine, with a performance period through May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVLN
    Delivery Order

This is a $30,442.50 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccines and has a completion date of June 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have any set-aside designation, indicating open competition.

Generated 5/17/25, 9:49 AM